Company Summary

Boehringer Ingelheim Ireland Limited was set up on Monday the 13th of December 1999. Their current partial address is Dublin 24, and the company status is Normal. The company's current directors have been the director of 0 other Irish companies between them. Boehringer Ingelheim Ireland Limited has 1 shareholder.

Company Name:Boehringer Ingelheim Ireland Limited
Company Status:NORMAL
Company Address:4045 Kingswood Road,
Citywest Business Park,
Dublin 24, Ireland
Telephone:+353 (0)1 295 9620
Website:www.boehringer-ingelheim.ie
Key Executive:Mr Moynihan
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Mr Moynihan is a Company Director of Boehringer Ingelheim Ireland Limited since 2013

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Boehringer Ingelheim Ireland Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
B10 CHANGE IN DIRECTORS/SECRETARY01/11/202504/12/2025Join Up
OTHER DIRECTORSHIP LIST01/11/202504/12/2025Join Up
Form B1C - Annual Return General30/09/202506/11/2025Join Up
FINANCIAL STATEMENT30/09/202506/11/2025Join Up
OTHER DIRECTORSHIP LIST30/09/202506/11/2025Join Up
THIS COMPANY HAS 112 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Boehringer Ingelheim Ireland Limited.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:28/01/2026
Latest Accounts Filed:06/11/2025
Report Based on Accounts:31/12/2024
Next Set of Accounts Due:30/09/2026
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Boehringer Ingelheim Ireland Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Boehringer Ingelheim Ireland Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Boehringer Ingelheim Ireland Limited and Anti-Money Laundering checks (AML checks) on Boehringer Ingelheim Ireland Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Boehringer Ingelheim Ireland Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

AML Compliance: What Businesses Need to Be Ready For

12/05/2026

AML Compliance: What Businesses Need to Be Ready For

Read More »

Risk Audit: Clearer Insight Across Your Portfolio

01/05/2026

In today's trading environment, risk rarely presents itself in a single moment. Credit profiles shift, financial resilience weakens, and company status changes can occur quietly in the background.

Read More »

ESG Insight for Smarter Business Decisions

27/04/2026

As we recently marked Earth Day 2026, the focus on sustainability has highlighted a simple reality: ESG is now a practical part of everyday business decision-making.

Read More »

Q1 Insights: Shifts in Leadership and Credit Dynamics

17/04/2026

While strong new business formation set a positive tone for the opening quarter of 2026, the wider financial and governance picture reveals a more nuanced environment.

Read More »